Abstract 1404: The nuclear coactivator amplified in breast cancer 1 promotes the initiation and the development of ductal carcinomain situ.

Author(s):  
Virginie Ory ◽  
Elena Tassi ◽  
Luciane Cavalli ◽  
Francisco Saenz ◽  
Tabari Baker ◽  
...  
2013 ◽  
Vol 2013 ◽  
pp. 1-7 ◽  
Author(s):  
Anita Bane

Ductal carcinomain situis a proliferation of malignant epithelial cells confined to the ductolobular system of the breast. It is considered a pre-cursor lesion for invasive breast cancer and when identified patients are treated with some combination of surgery, +/− radiation therapy, and +/adjuvant tamoxifen. However, no good biomarkers exist that can predict with accuracy those cases of DCIS destined to progress to invasive disease or once treated those patients that are likely to suffer a recurrence; thus, in the era of screening mammography it seems likely that many patients with DCIS are overtreated. This paper details the parameters that should be included in a pathology report for a case of DClS with some explanations as to their importance for good clinical decision making.


1995 ◽  
Vol 64 (1) ◽  
pp. 18-26 ◽  
Author(s):  
Dermot S. Murphy ◽  
Peter McHardy ◽  
Jacqueline Coutts ◽  
Elizabeth A. Mallon ◽  
W. David George ◽  
...  

Breast Cancer ◽  
2001 ◽  
Vol 8 (3) ◽  
pp. 259-259
Author(s):  
Shu Ichihara ◽  
Yasuyuki Sato ◽  
Tokiko Endo

2013 ◽  
Vol 2 (3) ◽  
pp. 245-256
Author(s):  
Soley Bayraktar ◽  
Banu Arun ◽  
Stefan Glück

1997 ◽  
Vol 84 (2) ◽  
pp. 145-146 ◽  
Author(s):  
M. J. Silverstein

Sign in / Sign up

Export Citation Format

Share Document